AbSorber AB - Product Pipeline Analysis, 2013 Update - New Report Available

AbSorber AB (AbSorber) is a biotechnology company. The company develops products for allogeneic transplantation. Its product XM-ONE detects antibodies specific for endothelial specific antigens and antibodies specific to transplantation antigens. AbSorber operates through xenotransplantation, and develops techniques for removing antibodies against alpha-Gal and for reducing the immunogenicity of neural stem cells. Its products are used in the treatment of neurological disorders. The company conducts researches on developing ABO Columns, ABO diagnostics, artificial vessel grafts. It operates as a subsidiary of Allenex AB. AbSorber is headquartered in Stockholm, Sweden.

This report is a source for data, analysis and actionable intelligence on the AbSorber AB portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Full Report Details at
- http://www.fastmr.com/prod/606047_absorber_ab_product_pipeline_analysis_2013_update.aspx?afid=301

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

* Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
* Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
* Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
* Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
* Data on relevant clinical trials and product patent details, wherever applicable.
* Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Get this Report

* Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
* Design and develop your product development, marketing and sales strategies.

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Ortho-Clinical Diagnostics Inc. - Product Pipeline Analysis, 2013 Update
- Alere Inc. (ALR) - Product Pipeline Analysis, 2013 Update
- Singulex, Inc. - Product Pipeline Analysis, 2013 Update
- XEPTAGEN SpA - Product Pipeline Analysis, 2013 Update
- GE Healthcare - Product Pipeline Analysis , 2013 Update